Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
Details for Australian Patent Application No. 2008200847 (hide)
International Classifications
Event Publications
13 March 2008 Complete Application Filed
22 May 2008 Section 223 Application Allowed
Miravant Pharmaceuticals, Inc. The time in which to make a further application for a divisional patent has been extended to 08 Mar 2008. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
29 May 2008 Application Open to Public Inspection
Published as AU-A-2008200847
24 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser